Reducing PIAS1 in both HD mouse models and patient‐derived iPSC neurons normalized disease‐associated transcriptional dysregulation, restored PNKP enzymatic activity impaired by mutant HTT, and improved genomic integrity [508]. This evidence concerns the gene PNKP and Huntington disease.